Murine herpesvirus pathogenesis: A model for the analysis of molecular mechanisms of human gamma herpesvirus infections

Acta Microbiologica et Immunologica Hungarica

Volumn 52, Issue 1, 2005, Pages 41-71

  Rajcani J ^a   Kudelova M ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

Animal model for human disease; Gamma herpesviruses; Latency; Lymphoproliferation; Murine herpesvirus; Pathogenesis; Virus genes

Indexed keywords

CYCLINE; PROTEIN BCL 2; VIRUS DNA;

ARTICLE; B LYMPHOCYTE; CELL DIVISION; CONTROLLED STUDY; DNA SEQUENCE; GENE FUNCTION; HERPES VIRUS; HERPES VIRUS INFECTION; LUNG ALVEOLUS; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MACROPHAGE; MOUSE; MURID HERPESVIRUS 4; NONHUMAN; T LYMPHOCYTE; VIRUS CARRIER; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALIA; GAMMAHERPESVIRINAE; HERPES; HERPESVIRIDAE; MURID HERPESVIRUS 4; MURINAE; MURINE HEPATITIS VIRUS; RODENTIA;

EID: 18944364669     PISSN: 12178950     EISSN: None     Source Type: Journal    
DOI: 10.1556/AMicr.52.2005.1.2     Document Type: Article

References (98)

1. Ahn, J. W., Powell, K. L., Kellam, P., Alber, D. G.: Gammaherpesvirus lytic gene expression as characterized by DNA array. J Virol 76, 6244-6256 (2002).
2. Alcami, A.: Structural basis of the herpesvirus M3 chemokine interaction. Trends in Microbiol 11, 791-792 (2003).
3. Bellows, D. S., Chau, N., Lee, P., Lazebnik, Y., William, H., Burns, W. H., Hardwick, J. M.: Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol 74, 5024-5031 (2000).
4. Belz, G. T., Doherty, P. C.: Virus-specific and bystander CD8+ T-cell proliferation in the acute and persistent phases of a gammaherpesvirus infection. J Virol 75, 4435-4438 (2001).
5. Blackman, M. A., Flano, E., Usherwood, E., Woodland, D. L.: Murine gamma-herpes virus-68: a mouse model for infectious mononucleosis? Mol Med Today 6, 488-490 (2000).
6. Blašković, D., Stanćeková, M., Svobodová, J., Mistríková, J.: Isolation of five strains of herpesviruses from two species of free-living small rodents. Acta Virol 24, 468-473 (1980).
7. Blašković, D., Stančeková, D., Rajćáni, J.: Experimental pathogenesis of murine herpesvirus in newborn mice. Acta Virol 28, 225-231 (1984).
8. Boshoff, C., Endo, Y., Collins, P. D., Takeuchi, Y., Reeves, J. D., Schweickart, V. L., Siani, M. A., Sasaki, T., Williams, T. J., Gray, P. W., Moore, P. S., Chang, Y., Weiss, R. A.: Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278, 290-294 (1997).
9. Bowden, R. J., Simas, J. P., Davis, A. J., Efstathiou, S.: Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency. J Gen Virol 78, 1675-1687 (1997).
10. Brown, H. J., Song, M. J., Deng, H., Wu, T. T., Cheng, G., Sun, R.: NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol 77, 8532-8540 (2003).
11. Chang, Y., Moore, P. S., Talbot, S. J.: Cyclin encoded by KS herpesvirus. Nature 382, 410-411 (1996).
12. Chang, E. H. Y., Nicholas, J., Bellows, D. S., Hayward, G. S., Guo, H. G., Reitz, M. S., Hardwick, J. M.: A bcl-2 homolog encoded by Kaposi's sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimer with Bax or Bak. Proc Natl Acad Sci USA 94, 690-694 (1997).
13. Čiampor, F., Stančeková, M., Blašković , D.: Electron microscopy of rabbit embryo fibroblasts infected with herpesvirus isolates from Clethrionomys glareolus and Apodemus flavicollis. Acta Virol 25, 101-107 (1981).
14. Dairaghi, D. J., Fan, R. A., McMaster, B. E., Hanley, M. R., Schall, T. J.: HHV-8 encoded vMIP-1 selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J Biol Chem 274, 21,569-21,574 (1999).
15. Damania, B., Choi, Joong-Kook, Jung, Jae U.: Signaling activities of gamma herpesvirus membrane proteins. J. Virol 74, 1593-1601 (2000).
16. Dittmer, D., Lagunoff, M., Renne, R., Staskus, K., Haase, A., Ganem, D. A.: A cluster of latently expressed genes in Kaposi's sarcoma - associated herpesvirus. J Virol 72, 8309-8315 (1998).
17. Ebrahimi, B., Dutia, B. M., Roberts, K. L., Garcia-Ramirez, J. J., Dickinson, P., Stewart, J. P., Ghazal, P., Roy, D. J., Nash, A. A.: Transcription profile of murine gamma-herpesvirus-68 lytic infection. J Gen Virol 84, 99-109 (2003).
18. Efstathiou, S., Ho, M., Hall, S., Styles, C. J., Scott, S. D., Gompels, U. A.: Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol 71, 1365-1372 (1990).
19. Farrel, P. J.: Epstein-Barr virus. In O'Brien (ed.): Genetic Maps. Cold Spring Harbor Press, New York, 1992, pp. 120-133.
20. Flano, E., Husain, S. M., Sample, J. T., Woodland, D. L., Blackman, M. A.: Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 165, 1074-1081 (2000).
21. Flano, E., Kim, I. J., Moore, J., Woodland, D. L., Blackman, M. A.: Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol 170, 3828-3834 (2003).
22. Friborg, J. R., Kong, W., Hottiger, M. O., Nabel, G. J.: p53 inhibition of by the LANA protein of KSHV protects against cell death. Nature 402, 889-894 (1999).
23. Fowler, P., Marques, S., Simas, J. P., Efstathiou, S.: ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J Gen Virol 84, 3405-3416 (2003).
24. Husain, S. M., Usherwood, E. J. H., Dyson, E. J., Coleclough, C., Coppola, M. A., Woodland, D. L., Blackman, M. A., Stewart, J. P., Sample, J. T.: Murine gamma herpesvirus M2 gene is latency-associated and its protein a target for CD8+ T lymphocytes. Proc Natl Acad Sci USA 96, 7508-7513 (1999).
25. Jacoby, M. A., Virgin, H. W., Speck, S. H.: Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J Virol 76, 1790-1801 (2002).
26. Kawahara, A., Kobayashi, T., Nagata, S.: Inhibition of Fas-induced apoptosis by Bcl-2. Oncogene 19, 2549-2554 (1998).
27. Kieff, E., Rickinson, A. B.: Epstein-Barr virus and its replication. In Knipe, D. M., Howley, P. M. (eds). Fields Virology. 4th ed. Pippincott-Williams & Wilkins, Philadelphia, 2001, pp. 2311-2573.
28. Komiyama, T., Ray, C. A., Pickup, D. J.: Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin crmA: an example of cross-class inhibition. J Biol Chem 269, 19,331-19,337 (1994).
29. Liu, L., Usherwood, E. J., Blackman, A. M., Woodland, D. L.: T cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J Virol 73, 9849-9857 (1999).
30. Liu, S., Pavlova, I. V., Virgin, I. V. H. W., Speck, S. H.: Characterization of gammaherpesvirus 68 gene 50 transcription. J Virol 74, 2029-2037 (2000).
31. Lukac, D. M., Renne, R., Kirshner, J. R., Ganem, D.: Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252, 304-312 (1998).
32. Lukac, D. M., Kirshner, J. R., Ganem, D.: Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73, 9348-9361 (1999).
33. Mačáková, K., Matis, J., Režuchová, I., Kúdela, O., Rašlová, H., Kúdelová, M.: Murine gammaherpesvirus M7 gene encoding gp150: difference in the sequence between 72 and 68 strains. Virus Genes 26, 89-95 (2003).
34. Marques, S., Efstathiou, S., Smith, K. G., Haury, M., Simas, J. F.: Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol 77, 7308-7318 (2003).
35. Martinez-Guzman, D. A., Rickabough, T., Wu, T. T., Brown, H., Cole, S., Song, M. J., Tong, L., Sun, R.: Transcription program of murine gammaherpesvirus. J Virol 77, 10,488-10,503 (2003).
36. Mistríková, J., Remeňová, A., Leššo, J., Stančeková, M.: Replication and persistence of murine herpesvirus 72 in lymphatic system and peritoneal blood mononuclear cells of Balb/c mice. Acta Virol 38, 151-156 (1994).
37. Mistríková, J., Furdíková, D., Oravcová, I., Rajčáni, J.: Effect of immunosuppression on Balb/c mice infected with murine herpesvirus. Acta Virol 40, 41-44 (1996).
38. Mistríková, J., Rajčáni, J., Mrmusová, M., Oravcová, I.: Chronic infection of Balb/c mice with murine herpesvirus 72 is associated with neoplasm development. Acta Virol 40, 297-301 (1996).
39. Mistríková, J., Mrmusová, M.: Detection of abnormal lymphocytes in the blood of Balb/c mice infected with murine herpesvirus strain 72. Acta Virol 42, 79-82 (1998).
40. Mistríková, J., Mrmusová, M., Ď urmanová, V., Rajčáni, J.: Increased neoplasm development due to immunosuppressive treatment with FK.506 in Balb/c mice persistently infected with mouse herpesvirus. Viral Immunology 12, 237-247 (1999).
41. Mistríková, J., Rašlová, H., Mrmusová, M., Kúdelová, M.: Murine herpesvirus. Acta Virol 44, 211-226 (2000).
42. Mistriková, J., Moško, T., Mrmusová, M.: Pathogenetic characterization of a mouse herpesvirus isolate Sumava. Acta Virol 46, 41-46 (2002).
43. Mistríková, J., Mrmusová- Šupolíková, M., Rajčáni, J.: Leukemia like syndrome in Balb/c mice infected with the lymphotropic gamma herpesvirus MHV-Šumava: an analogy to EBV infection. Neoplasma 51, 71-76 (2004).
44. Mittnacht, S., Boshoff, Ch.: Viral cyclins. Rev Med Virol 10, 175-184 (2000).
45. Moorman, N. J., Willer, D. O., Speck, S. H.: The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol 77, 10,295-10,303 (2003).
46. Moore, P. S., Chang, Y.: Molecular virology of Kaposi's sarcoma-associated herpesvirus. Phil Trans R Soc Lond B 356, 499-516 (2001).
47. Moorman, N. J., Virgin, I. V. H. W., Speck, S. H.: Disruption of the gene encoding the HV68 v-GPCR leads to decreased efficiency of reactivation from latency. Virology 307, 179-190 (2003).
48. Mrmusová, M., Horváthová, M., Klobuš ická, M., Mistríková, J.: Immunotyping of leukocytes in peripheral blood of Balb/c mice infected with mouse herpesvirus isolate 72. Acta Virol 46, 19-24 (2002).
49. Nemerow, G. R., Wolfert, R., McNaughton, M. E., Cooper, N. R.: Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 55, 347-351 (1985).
50. Nicholas, J., Cameron, K. R., Honess, R. W.: Herpesvirus saimiri encodes homologs of G protein-coupled receptors and cyclins. Nature 355, 362-365 (1992).
51. Nicholas, J.: Evolutionary aspects of oncogenic herpesviruses. J Clin Pathol (Mol Pathol) 53, 222-237 (2000).
52. Parry, C. M., Simas, J. P., Smith, C. A., Stewart, A. C., Minson, C. A., Efstathiou, S., Alcami, A.: A broad spectrum secreted chemokine-binding protein encoded by a herpesvirus. J Exp Med 191, 573-578 (2000).
53. Pavlova, I. V., Virgin, H. W., Speck, S. H.: Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication. J Virol 77, 5731-5739 (2003).
54. Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, M. T., Gerritsen, M. E.: Novel inhibitors of cytokine induced IkB phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vitro. J Biol Chem 272, 21096-21103 (1997).
55. Preston, C. M.: Repression of viral transcription during herpes simplex virus latency. J Gen Virol 81, 1-9 (2000).
56. Rajčáni, J., Ďurmanová, V.: Early expression of herpes simplex virus proteins and reactivation of latent infection. Folia Microbiol 45, 7-28 (2000).
57. Rajčáni, J., Kúdelová, M.: Gamma herpesviruses: pathogenesis of infection and cell signaling. Folia Microbiol 48, 291-318 (2003).
58. Rajčáni, J., Blaškovič, D., Svobodová, J., Ćiampor, F., Hučková, D., Stančeková, D.: Pathogenesis of acute and persistent murine herpesvirus infection in mice. Acta Virol 29, 51-60 (1985).
59. Rajčáni, J., Bustamenete de Contreras, L. R., Svobodová, J.: Corneal inoculation of murine herpesvirus in mice: the absence of neural spread. Acta Virol 31, 25-30 (1987).
60. Rašlová, H., Mistríková, J., Kúdelová, M., Mishal, Z., Sarasin, A., Blangy, D., Berebbi, M.: Immunophenotypic study of atypical lymphocytes generated in peripheral blood and spleen of nude mice after MHV-72 infection. Viral Immunol 13, 313-327 (2000).
61. Rašlová, H., Berebbi, M., Rajčáni, J., Sarasin, A., Matis, J., Kúdelová, M.: Susceptibility of mouse mammary glands to murine gammaherpesvirus 72 (MHV-72) infection: evidence of MHV-72 transmission via breast milk. Microbial Pathogenesis 31, 47-58 (2001).
62. Rochford, R., Lutzke, M. L., Alfinito, R. S., Clavo, A., Cardin, R. D.: Kinetics of murine gammaherpesvirus 68 gene expression following infection of murine cells in culture and in mice. J Virol 75, 4955-4963 (2001).
63. Roy, D. J., Ebrahimi, B. C., Dutia, B. M., Nash, A. A., Stewart, J. P.: Murine gammaherpesvirus M11 gene product inhibits apoptosis and is expressed during virus persistence. Arch Virol 145, 2411-2420 (2000).
64. Rosenkilde, M. M., Kledal, T. N., Brauner-Osborne, H., Schwartz, T. W.: Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF74. J Biol Chem 274, 956-961 (1999).
65. Sarawar, S. R., Lee, B. J., Anderson, M., Teng, Y. Ch., Zuberi, R., vonGejsen, S.: Chemokine induction and leukocyte trafficking to the lungs during murine gammaherpesvirus 68 (MHV-68) infection. Virology 293, 54-62 (2002).
66. Simas, G. A., Bowden, R. J., Paigne, V., Efstathiou, S.: Four tRNA-like sequences and a serpin homologue encoded by murine gammaherpesvirus 68 are dispensable for lytic replication in vitro and latency in vivo. J Gen Virol 79, 149-153 (1998).
67. Stevenson, P. G., Doherty, P. C.: Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol 72, 943-949 (1998).
68. Stevenson, P. G., Belz, G. T., Castrucci, M. R., Altman, J. D., Doherty, P. C.: A gammaherpesvirus sneaks through a CD8+ T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci USA 96, 9281-9286 (1999).
69. Stevenson, P. G., Efstathiou, S., Doherty, P. C., Lehner, P. J.: Inhibition of MHC class I-restricted by gamma-2 herpesviruses. Proc Natl Acad Sci USA 97, 8455-8460 (2000).
70. Stevenson, P. G., May, S. J., Smith, X. G., Marques, S., Adler, H., Koszinowski, U. H., Simas, J. P., Efstathiou, S.: K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3, 733-740 (2002).
71. Stewart, J. P., Usherwood, E. J., Ross, A., Dyson, H., Nash, A. A.: Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 187, 1941-1951 (1998).
72. Stewart, J. P., Micali, N., Usherwood, E. J., Bonina, L., Nash, A. A.: Murine gammaherpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: A model system for gamma-herpesvirus vaccination. Vaccine 17, 152-157 (1999).
73. Stine, J. T., Wood, C., Hill, M., Epp, A., Raport, C. J., Schweickart, V. L., Endo, Y., Sasaki, T., Simmons, G., Boshoff, C., Clapham, P., Chang, Y., Moore, P., Gray, P. W., Chantry, D.: KSHV encoded CC chemokine vMIPIII is a CCR4 agonist, stimulates angiogenesis and selectively chemoattracts TH2 cells. Blood 95, 1151-1157 (2000).
74. Sun, R., Lin, S. F., Gradoville, L., Yuan, Y., Zhu, F., Miller, G.: A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 95, 10866-10871 (1998).
75. Sunil-Chandra, N. P., Efstathiou, S., Arno, J., Nash, A. A.: Virological and pathological features of mice with marine gammaherpesvirus. J Gen Virol 73, 2347-2356 (1992).
76. Sunil-Chandra, N. P., Efstathiou, S., Amo, J., Nash, A. A.: Murine gammaherpesvirus establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 73, 3275-3279 (1992).
77. Sunil-Chandra, N. P., Efstathiou, S., Nash, A. A.: Interactions of murine gammaherpesvirus 68 with B and T cell lines. Virology 193, 825-833 (1993).
78. Sunil-Chandra, N. P., Fazakerley, A. J., Nash, A. A.: Lymphoproliferative disease in mice infected with murine gamma herpesvirus 68. Am. J. Pathol 145, 818-826 (1994).
79. Svobodová, J., Blaškovič, D., Mistrí ková, J.: Growth characteristics of herpesviruses isolated from free living small rodents. Acta Virol 26, 256-263 (1982).
80. Swanton, C., Mann, D. J., Fleckenstein, B., Neipel, F., Peters, G., Jones, N.: Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390, 184-187 (1997).
81. Terry, L. A., Stewart, J. P., Nash, A. A., Fazakerly, J. K.: Murine gammaherpesvirus-68 infection of and persistence the central nervous system. J Gen Virol 81, 2535-2643 (2000).
82. Tibbetts, S. A., Loh, J., van Berkel, V., McClellan, J. S., Jacoby, M. A., Kapadia, S. B., Speck, S. H., Virgin, I. V. H. W.: Establishment and maintenance of gammaherpesvirus latency are independent if infective dose and route of infection. J Virol 77, 7696-7701 (2003).
83. Usherwood, E. J., Stewart, J. P., Robertson, K., Allen, D. J., Nash, A. A.: Absence of splenic latency in murine gammaherpesvirus 68-infected mice. J Gen Virol 77, 2819-2825 (1996).
84. Usherwood, E. J., Ross, A. J., Allen, D. J., Nash, A. A.: Murine gammaherpesvirus induced splenomegaly: a critical role for CD4 cells. J Gen Virol 77, 627-630 (1996).
85. Usherwood, E. J., Roy, D. J., Ward, K., Surman, S. L., Dutia, B. M., Blackman, M. A., Stewart, J. P., Woodland, D. L.: Control of gammaherpesvirus latency by latent antigen-specific CD8+ T cells. J Exp Med 192, 943-952 (2000).
86. Usherwood, E. J., Ward, K., Blackman, M. A., Stewart, J. P., Woodland, D. L.: Latent antigen vaccination in a model gammaherpesvirus infection. J Virol 75, 8283-8288 (2001).
87. van Berkel, V., Preiter, K., Virgin, I. V. H. W., Speck, S. H.: Identification and initial characterization of the murine gammaherpesvirus 68 gene M3, encoding an abundantly secreted protein. J Virol 73, 5110-5122 (1999).
88. van Dyk, L. F., Hess, J. L., Katz, J. D., Jacoby, M., Speck, S. H., Virgin, H. I.: The murine gammaherpesvirus 68 v-cyclin is a oncogene that promotes cell cycle progression in primary lymphocytes. J Virol 73, 5119-5122 (1999).
89. vanDyk, L. F., Virgin, I. V. H. W., Speck, S. H.: The murine gammaherpesvirus 68 v-Cyclin is a critical regulator of reactivation from latency. J Virol 74, 7451-7461 (2000).
90. th ICTV Report, Academic Press, San Diego - New York - London - Tokyo, 2000, pp. 220-226.
91. Virgin, I. V. H. W., Latreille, P., Wamsley, P., Hallsworth, K., Week, K. E., Dal Canto, A. J., Speck, S. H.: Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71, 5894-5904 (1997).
92. Virgin, H. W. I. V., Presti, R. M., Li, X. Y., Liu, C., Speck, S. H.: Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J Virol 73, 2321-2332 (1999).
93. Wakeling, M. N., Roy, D. J., Nash, A. A., Stewart, J. P.: Characterization of the murine gammaherpesvirus ORF74 product: A novel oncogenic G protein-coupled receptor. J Gen Virol 82, 1187-1197 (2001).
94. Week, K. E., Barkon, M. L., Yoo, L. I., Speck, S. H., Virgin, I. V. H. W.: Mature B cells are required for acute splenic infection, but not for establishment of latency by murine gammaherpesvirus. J Virol 70, 6775-6780 (1996).
95. Weck, K. E., Kim, S. S., Virgin, I. V. H. W., Speck, S. H.: Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol 73, 3273-3283 (1999).
96. Whitehouse, A., Carr, I. M., Griffiths, J. C., Meredith, D. M.: The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R protein, is transcribed from two distinct promoters of different temporal phases. J Virol 71, 2550-2554 (1997).
97. Wu, T-T., Usherwood, E. J., Stewart, J. P., Nash, A. A., Sun, R.: Rta of murine gammaherpesviras 68 reactivates the complete lytic cycle from latency. J Virol 74, 3659-3667 (2000).
98. Yang, T. Y., Chen, S. C., Leach, M. W., Manfra, D., Homey, B., Wiekowksi, M., Sullivan, L., Jenh, C. H., Narula, S. K., Chensue, S. W., Lira, S. A.: Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191, 445-454 (2000).